Over the past six months, The Ensign Group’s stock price fell to $182.42. Shareholders have lost 10.9% of their capital, which is disappointing considering the S&P 500 has climbed by 12.9%. This might have investors contemplating their next move.
Given the weaker price action, is now an opportune time to buy ENSG? Find out in our full research report, it’s free.
Why Does ENSG Stock Spark Debate?
Founded in 1999 and named after a naval term for a flag-bearing ship, The Ensign Group (NASDAQ: ENSG) operates skilled nursing facilities, senior living communities, and rehabilitation services across 15 states, primarily serving high-acuity patients recovering from various medical conditions.
Two Things to Like:
1. Skyrocketing Revenue Shows Strong Momentum
A company’s long-term performance is an indicator of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Luckily, The Ensign Group’s sales grew at an impressive 17.7% compounded annual growth rate over the last five years. Its growth surpassed the average healthcare company and shows its offerings resonate with customers.
2. Outstanding Long-Term EPS Growth
Analyzing the long-term change in earnings per share (EPS) shows whether a company’s incremental sales were profitable — for example, revenue could be inflated through excessive spending on advertising and promotions.
The Ensign Group’s EPS grew at a spectacular 13.9% compounded annual growth rate over the last five years. This performance was better than most healthcare businesses.
One Reason to Be Careful:
Demand Slips as Sales Volumes Slide
Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful Specialized Medical & Nursing Services company because there’s a ceiling to what customers will pay.
The Ensign Group’s units sold came in at 447,826 in the latest quarter, and they averaged 18.5% year-on-year declines over the last two years. This performance was underwhelming and implies there may be increasing competition or market saturation. It also suggests The Ensign Group might have to lower prices or invest in product improvements to grow, factors that can hinder near-term profitability. 
Final Judgment
The Ensign Group’s merits more than compensate for its flaws. After the recent drawdown, the stock trades at 22.1× forward P/E (or $182.42 per share). Is now the time to initiate a position? See for yourself in our full research report, it’s free.
Stocks We Like Even More Than The Ensign Group
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
